Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01153282 · ClinicalTrials.gov registry record
Physical Functional Side Effects of Taxane Chemotherapy for Breast Cancer
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 25
- Enrollment target
NCT01153282 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 25 participants.
The verdict
NCT01153282 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Determine the characteristics of symptoms and functional impairment associated with chemotherapy induced peripheral neuropathy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01153282
The ClinicalTrials.gov registry entry for NCT01153282 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01153282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01153282 about?
NCT01153282 is a clinical study titled "Physical Functional Side Effects of Taxane Chemotherapy for Breast Cancer". Determine the characteristics of symptoms and functional impairment associated with chemotherapy induced peripheral neuropathy.
What is the current status of trial NCT01153282?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2010-06. Estimated completion is 2012-05.
Who is sponsoring clinical trial NCT01153282?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.